what makes retatrutide different 🧬 SEMAGLUTIDE vs TIRZEPATIDE vs 🧬 Understanding the difference could help you make more informed decisions about weight management and metabolic health. 👇 🔹 Semaglutide Targets GLP-1 receptors to help reduce Retatrutide vs. Tirzepatide: Dual vs.

Cell-based experiments also demonstrate receptor-dependent signaling changes when Retatrutide interacts with GLP-1R, GIPR, or GCGR expressing cells

GLP-1s & NAION

This once-weekly prefilled injector, designed for both type 2 diabetes and obesity, expands the drug's availability from the initial 2.5mg and 5mg vials to include six strengths (2.5, 5, 7.5, 10, 12.5, and 15mg)

It comes down to how the drugs are designed: while semaglutide acts only on GLP-1 receptors, tirzepatide is a dual-target drug that also acts on GIP receptors (GIP, or gastric inhibitory polypeptide, is another hormone like GLP-1 that helps regulate insulin and blood sugar)

These are typically dose dependent, occur most frequently upon initiation or dose escalation, and often diminish over time [84]

When is retatrutide expected to be submitted for the US FDA approval and its launch